期刊文献+

VEGF和pRb2/p130、CyclinD1在子宫内膜癌中的表达及意义 被引量:6

The expression and significance of pRb2 / p130,Cyclin D1 and VEGF in endometrial carcinoma
下载PDF
导出
摘要 目的:探讨pRb2/p130、Cyclin D1蛋白和VEGF在正常子宫内膜、子宫内膜增殖症、非典型子宫内膜增殖症和子宫内膜癌中的表达、相关性及与临床病理特征的关系。方法:免疫组织化学En Vision二步法检测pRb2/p130、Cyclin D1蛋白和VEGF在30例正常增生期子宫内膜、30例子宫内膜增殖症、40例非典型子宫内膜增殖症和68例子宫内膜癌中的表达。结果:在非典型子宫内膜增殖症中,VEGF的表达显著高于正常子宫内膜(P<0.05),与Cyclin D1呈正相关(P=0.013)。子宫内膜癌中,VEGF的表达分别与组织学分级、雌激素受体(ER)相关。VEGF的表达显著高于子宫内膜增殖症(P<0.05),VEGF与pRb2/p130呈负相关(r=-0.243,P=0.045),分别与CyclinD 1蛋白、ER呈正相关(r=0.337,P=0.005;r=4.628,P=0.031)。结论:pRb2/p130、CyclinD 1蛋白和VEGF在非典型子宫内膜增殖症和子宫内膜癌中的异常表达,结合在一起可能成为癌前病变和子宫内膜癌侵袭的筛查指标。子宫内膜癌中,ER可能调控着VEGF的产生。 Objective:To investigate the expressions of pRb2/p130,CyclinD1 protein and VEGF,their correlation and relationship with the pathological clinical features of normal endometrial tissue,endometrial hyperplasia,atypical endometrial hyperplasia and human endometrial carcinoma. Methods:Thirty normal endometrial tissue,30 endometrial hyperplasia,40 atypical endometrial hyperplasia and 68 endometrial carcinomas were collected. Immunohistochemistri-cal methods were used to detect their pRb2/p130,CycinD1 protein and VEGF expressions. Results:In the atypical endometrial hyperplasia,the expressions of VEGF were significantly higher than that of normal(p﹤0. 05). VEGF and CyclinD1 expression were positive correlated. In the endometrial carcinomas,the expression of VEGF was associated with tumor grade and ER. The expressions of VEGF were significantly higher than that of endometrial hyperplasia( p﹤0. 05). There was negative correlation between the expressions of pRb2/p130 protein and that of VEGF(r= -0. 243, p=0. 045). There was positive correlation between the expressions of CyclinD1 protein,ER and that of VEGF(r=0. 337,p=0. 005;r =4. 628,p =0. 031,respectively). Conclusion:The abnormal expression of pRb2/p130,Cy-clinD1 protein and VEGF in the atypical endometrial hyperplasia and that of endometrial carcinomas,combined to-gether,may be as screening index of precancerous lesions and endometrial cancer aggressiveness. Estrogen-receptor may be regulate production of VEGF.
出处 《现代肿瘤医学》 CAS 2015年第11期1575-1578,共4页 Journal of Modern Oncology
基金 广西卫生厅科研立项课题(编号:Z2013282)
关键词 PRB2/P130 CYCLIND1 VEGF 子宫内膜癌 免疫组化 pRb2/p130 CyclinD VEGF endometrial carcinoma immunohistochemical
  • 相关文献

参考文献11

  • 1莫秋荣,梁科庆,农勤高,苏赓,温伟.pRb2/p130和CyclinD1在子宫内膜癌中的表达及临床意义[J].实用医学杂志,2014,30(7):1094-1097. 被引量:4
  • 2Claudio PP, Russo G, Kumar CA, et al. pRb2/p130, vascular endo- thelial growth factor, p27 (KIP1), and proliferating cell nuclear an- tigen expression in hepatocellular carrcinoma:Their clinical signifi- cance[J]. Clin Cancer Res,2004,10:3509 -3517.
  • 3Guset G, Costt S, Lazar E, et al. Expression of vascular endothelial growth factor(VEGF) and assessment of microvascular density with CD34 as prognstic markers for endometrial carcinoma [ J ]. Roma- nian J Morphol Embryol,2010,51 (4) :677 -682.
  • 4Fattaneh A, Tavassoil FA, Devilee P, et al. World Health Organiza- tion classification of tumours. Pathology and genetics of tumours of the breast and female genital organs [ M ]. Beijing : People's Health Publishing House ,2003:221 - 232.
  • 5孙峰瑞,杨华英,张素芬,时志民,王蕾,孙冬霞.子宫内膜癌中uPA、p-p38和VEGF的表达及意义[J].现代肿瘤医学,2012,20(7):1427-1430. 被引量:4
  • 6Mattioli E, Vogiazi P, Sun A, et al. Immunohistochemical analysis of pRb2/p130 ,VEGF, EZH2, p53, p16 ( INK4A), p27 ( KIP1 ), p21 ( WAF1 ), Ki - 67 expression patterns in gastric cancer [ J ]. J Cell Physio1,2007,210( 1 ) :183 - 191.
  • 7Sanseverino F,Santopietro R,Torricelli G, et al. pRb2/pl30 and VEGF expression in endometrial carcinoma in relation to angiogen- esis and histopathologic tumor grade [ J ]. Cancer Biol Ther,2006,5 (1) :84 -88.
  • 8简娜提.阿不力孜,拉莱.苏祖克.VEGF和CyclinD1在乳腺癌中的表达及其意义[J].新疆医科大学学报,2010,33(10):1213-1216. 被引量:3
  • 9慈超,刘雯蓓,常小丽,何彩凤,强娣.扁平苔藓皮损中STAT3、VEGF、CyclinD1的表达及其相关性研究[J].中国临床药理学与治疗学,2013,18(8):874-878. 被引量:2
  • 10黄晓芳,刘青云,庞战军.子宫肌瘤患者VEGF、ER及PR的表达及相关性[J].现代生物医学进展,2010,10(12):2308-2310. 被引量:9

二级参考文献52

  • 1韩彪,张现伟,刘健,蒋鹏.pRb2/p130、cyclin D1和MUC1在食管鳞癌中的表达[J].肿瘤防治研究,2006,33(9):649-652. 被引量:4
  • 2宋印利,王艳丽,姚东升.子宫内膜癌中血管内皮生长因子和微血管密度的表达[J].现代生物医学进展,2006,6(10):60-61. 被引量:4
  • 3张文军,李荣山.p38丝裂原活化蛋白激酶通路及其研究进展[J].医学综述,2007,13(9):663-665. 被引量:16
  • 4Hyder SM, Huang JC, Nawaz Z, et al. Relation of vascular endothelaial growth factor expression by estrogens and progestins [J], Envior Health Pers Peet, 2000, 108 (5):785.
  • 5De Leo V, Morgante G. Uterine flbromas and the hormonal pattern: the therapeutic consideration [J]. Minerva Ginecol,1996,48:533-538.
  • 6Fujinoto J, Sakaguchi H, Anki I, et al. Clinical implications of expression of vascular endothelial growth factor in metstatic lesion of ovarian cancers [J]. Br J Cancer, 2001, 85 (3): 313.
  • 7Senger R, Vande L, Brown F, et al. Vascular permeability factor (VPF, VEGF) in tumorbiology [J]. Cancer Metastasis Rev, 1993, 12 (3-4): 303-324.
  • 8Shinkanzk S, Bayle M, Lain G, et al Vascular endothelial cell growth factor(VEGF),an emerging target for carcinoma ehemotherapy[J].Curr Med Chem Anticarcinoma Agents,2003,3:95-117.
  • 9Manenti L, Paganoni P, Floriani I, et al. Expression levels of vascular endothelial growth factor, matrix metalloproteinases 2 and 9 and tissue inhibitor of metalloproteinases 1 and 2 in the plasma of patients with ovarian reinoma [J]. Eur J Cancer, 2003,39:1948.
  • 10Masayuki I.Prognostic significance of cyclinDI and E cadherin in patients with esophageal squamous cell carcinoma:multinstitutional retrospective analysis[J].J Am Coll Surg,2004,192(6):708-718.

共引文献17

同被引文献44

引证文献6

二级引证文献40

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部